ImmuCell Corporation

ICCC · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$2-$6-$2-$0
Dep. & Amort.$3$3$2$2
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$0-$2-$2-$2
Other Non-Cash-$0$0$0$0
Operating Cash Flow$0-$5-$2$1
Investing Activities
PP&E Inv.-$0-$2-$4-$3
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0-$0
Inv. Sales/Matur.$0$0$0$1
Other Inv. Act.$0$0$0$0
Investing Cash Flow-$0-$2-$4-$2
Financing Activities
Debt Repay.-$1$2$1-$0
Stock Issued$4$0$31$4
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$0-$0$0$0
Financing Cash Flow$3$2$1$4
Forex Effect$0$0$0$0
Net Chg. in Cash$3-$5-$4$3
Supplemental Information
Beg. Cash$1$6$10$7
End Cash$4$1$6$10
Free Cash Flow-$0-$7-$6-$2
ImmuCell Corporation (ICCC) Financial Statements & Key Stats | AlphaPilot